New adhesive to help heal shoulder labrum injuries
Biomolecule releasing adhesive for cell-mediated labral repair
This study is testing a new type of glue that helps heal shoulder injuries by not only fixing the tear but also helping the tissue grow back better, so patients can feel less pain and have a more stable shoulder after surgery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-10878898 on NIH RePORTER |
What this research studies
This research focuses on developing a novel biomolecule-releasing adhesive aimed at improving the healing of glenoid labrum tears in the shoulder. The approach involves using advanced chemistry techniques to create an adhesive that not only repairs the labrum but also promotes tissue regeneration. By enhancing the healing process, this research seeks to reduce the high rates of recurrent pain and instability that many patients experience after traditional surgical repairs. Patients participating in this research may benefit from a more effective treatment option that addresses the underlying issues of labral injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from glenoid labrum tears or injuries, particularly those who have not found relief from conventional surgical methods.
Not a fit: Patients with labral injuries that are not suitable for surgical intervention or those with other unrelated shoulder conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healing and recovery for patients with shoulder labrum injuries, reducing pain and instability.
How similar studies have performed: While similar approaches in cartilage and bone healing have shown promise, this specific application for glenoid labrum healing is relatively novel and has not been extensively tested.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Tang, Liping — University of Texas Arlington
- Study coordinator: Tang, Liping
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.